Over-the-Top vs. Anteromedial ACLR With Lateral Extraarticular Tenodesis
Launched by ANKARA CITY HOSPITAL BILKENT · Oct 27, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different surgical techniques for repairing a torn anterior cruciate ligament (ACL) in the knee. The first method, called the over-the-top (OTT) technique, is known for its simplicity and ability to maintain the natural position of the ACL, making it easier for some patients, especially those who have had previous surgeries. The second method combines another surgical approach called the anteromedial technique with a procedure called lateral extraarticular tenodesis (LET), which aims to improve knee stability and reduce the risk of re-injury, especially for athletes who play sports that involve sudden movements.
To participate in this trial, individuals should be between 18 and 50 years old and have an isolated ACL tear without any previous surgeries on the same knee. Participants will undergo surgery and be monitored for their recovery, including follow-up MRI and CT scans after one year. This study is important as it will help researchers understand which surgical method offers better outcomes for patients, such as improved knee stability and a quicker return to sports. If you or someone you know is dealing with an ACL injury, this trial could provide valuable insights into treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of an isolated anterior cruciate ligament (ACL) tear (isolated ligament injury).
- • Age between 18 and 50 years.
- • No previous history of surgery on the same knee.
- • MRI and CT scans performed at the end of the first postoperative year.
- Exclusion Criteria:
- • Presence of additional ligamentous injury (e.g., posterior cruciate ligament or collateral ligament) along with the ACL tear.
- • Incomplete clinical scores.
- • History of previous surgery on the same knee.
- • Presence or history of infection.
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Enejd Veizi, MD
Principal Investigator
Ankara City Hospital Bilkent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported